Canada markets open in 2 hours 56 minutes

Bright Minds Biosciences Inc. (DRUG.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
1.60000.0000 (0.00%)
At close: 03:47PM EDT
Currency in CAD

Valuation Measures4

Market Cap (intraday) 7.14M
Enterprise Value 1.24M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)1.26
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-64.44%
S&P500 52-Week Change 325.26%
52 Week High 38.5800
52 Week Low 30.0000
50-Day Moving Average 31.5466
200-Day Moving Average 32.1101

Share Statistics

Avg Vol (3 month) 31.2k
Avg Vol (10 day) 3500
Shares Outstanding 54.46M
Implied Shares Outstanding 64.73M
Float 83.18M
% Held by Insiders 135.48%
% Held by Institutions 14.78%
Shares Short (Apr 15, 2024) 4134
Short Ratio (Apr 15, 2024) 40.25
Short % of Float (Apr 15, 2024) 40.00%
Short % of Shares Outstanding (Apr 15, 2024) 40.00%
Shares Short (prior month Mar 15, 2024) 4558

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:5
Last Split Date 3Jul 14, 2023

Financial Highlights

Fiscal Year

Fiscal Year Ends Sept 30, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-38.42%
Return on Equity (ttm)-71.69%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-5.24M
Diluted EPS (ttm)-1.3300
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)5.93M
Total Cash Per Share (mrq)1.33
Total Debt (mrq)34.73k
Total Debt/Equity (mrq)0.61%
Current Ratio (mrq)7.69
Book Value Per Share (mrq)1.27

Cash Flow Statement

Operating Cash Flow (ttm)-4.48M
Levered Free Cash Flow (ttm)-2.91M